In the last trading session, 1.6 million Editas Medicine Inc (NASDAQ:EDIT) shares changed hands as the company’s beta touched 2.02. With the company’s per share price at $1.51 changed hands at $0.12 or 8.24% during last session, the market valuation stood at $126.41M. EDIT’s last price was a discount, traded about -311.92% off its 52-week high of $6.22. The share price had its 52-week low at $0.91, which suggests the last value was 39.74% up since then.
Analysts gave the Editas Medicine Inc (EDIT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.47. If we narrow down to specifics, the data shows that 0 out of 9 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 3 recommended EDIT as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight.
Editas Medicine Inc (NASDAQ:EDIT) trade information
Instantly EDIT was in green as seen at the end of in last trading. With action 4.14%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 18.90%, with the 5-day performance at 4.14% in the green. However, in the 30-day time frame, Editas Medicine Inc (NASDAQ:EDIT) is 18.90% up.
The consensus price target for the stock as assigned by Wall Street analysts is 12, meaning bulls need an upside of 87.42% from its current market value. According to analyst projections, EDIT’s forecast low is 5 with 35 as the target high. To hit the forecast high, the stock’s price needs a -2217.88% plunge from its current level, while the stock would need to soar -231.13% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -1.48%. The 2025 estimates are for Editas Medicine Inc earnings to increase by 36.66%, but the outlook for the next 5-year period is at 25.98% per year.
EDIT Dividends
Editas Medicine Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 9.4551% or 7.78 million shares worth $36.34 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 2.59 shares estimated at $3.91 million under it, the former controlled 3.10% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.62% of the shares, roughly 2.19 shares worth around $3.31 million.
